Gary Dubin
Director/Board Member at HILLEVAX, INC.
Profile
Gary Dubin is an Independent Director at HilleVax, Inc. He previously worked as the VP & Head-Late Clinical Development at GlaxoSmithKline Vaccines Srl from 2010 to 2015.
He also served as an Assistant Professor at the University of Pennsylvania.
Dr. Dubin holds a doctorate degree from the University of Pennsylvania.
Gary Dubin active positions
| Companies | Position | Start |
|---|---|---|
| HILLEVAX, INC. | Director/Board Member | 2022-02-28 |
Former positions of Gary Dubin
| Companies | Position | End |
|---|---|---|
Glaxosmithkline Vaccines Srl
 Glaxosmithkline Vaccines Srl BiotechnologyHealth Technology Glaxosmithkline Vaccines Srl engages in the development, production, and sale of biological preparations against infectious diseases. It offers vaccines for babies and children, teenagers and adults, travelers, and elderly people. The company was founded by Achille Sclavo in 1904 and is headquartered in Siena, Italy. | Corporate Officer/Principal | 2014-12-31 |
| University of Pennsylvania | Corporate Officer/Principal | - |
Training of Gary Dubin
| University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HILLEVAX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Glaxosmithkline Vaccines Srl
Glaxosmithkline Vaccines Srl BiotechnologyHealth Technology Glaxosmithkline Vaccines Srl engages in the development, production, and sale of biological preparations against infectious diseases. It offers vaccines for babies and children, teenagers and adults, travelers, and elderly people. The company was founded by Achille Sclavo in 1904 and is headquartered in Siena, Italy. | Health Technology |
- Stock Market
- Insiders
- Gary Dubin
